Device and method for monitoring and assessment of movement disorder symptoms
First Claim
1. A method of monitoring the efficacy of either a drug or deep brain stimulation (DBS) therapy during treatment at alleviating a subject'"'"'s Parkinson'"'"'s disease symptoms, the method comprising the steps of:
- a) administering at least one dose of a drug or DBS therapy treatment to the subject;
b) applying at least one sensor to the subject over a period of time, the sensor adapted for measuring movement of at least one of the subject'"'"'s extremities and to be in wired or wireless communication with a processor, the sensor and processor being part of a movement disorder monitoring device further comprising a memory, the processor adapted to process and analyze data collected with the at least one sensor and further to quantify severity of the subject'"'"'s movement disorder symptoms;
c) using the at least one sensor to collect movement data from the subject over a period of time;
d) preprocessing measured movement data with the processor of the movement disorder monitoring device;
e) quantifying severity of the subject'"'"'s movement disorder symptoms with the processor of the movement disorder monitoring device;
f) recording, by the subject, a journal or diary entry through an input on the movement disorder monitoring device at the subject'"'"'s discretion;
g) transmitting the preprocessed movement data, quantified symptom severity, and/or journal or diary entry to a remote database;
h) analyzing the preprocessed movement data, quantified symptom severity, and/or journal or diary entry with a second processor to determine the efficacy of the drug or DBS therapy at alleviating the subject'"'"'s Parkinson'"'"'s disease symptoms and to determine whether the dose of drug or DBS therapy administered to the subject should be changed; and
i) adjusting the subject'"'"'s dose of drug or DBS parameters according to the results of the analysis.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention is directed to a device and method for monitoring and assessment of movement disorder symptoms. The device and method disclosed herein are particularly amenable to remote monitoring of a subject'"'"'s movement disorder symptoms. Briefly stated, in certain preferred embodiments of the present invention the movement disorder monitoring device accompanies a subject to a remote location where the device is used to record data relating to the severity of a subject'"'"'s movement disorder symptoms over a period of time. This data is then subsequently used by physicians or other clinicians in optimizing and assessing treatment options directed at alleviating a subject'"'"'s movement disorder symptoms. The method and device of the present invention can be used to monitor symptoms of a number of movement disorders including but not limited to dystonia, essential tremor, Huntington'"'"'s disease, various ataxias, multiple sclerosis, psychogenic tremor, and Parkinson'"'"'s disease.
-
Citations
19 Claims
-
1. A method of monitoring the efficacy of either a drug or deep brain stimulation (DBS) therapy during treatment at alleviating a subject'"'"'s Parkinson'"'"'s disease symptoms, the method comprising the steps of:
-
a) administering at least one dose of a drug or DBS therapy treatment to the subject; b) applying at least one sensor to the subject over a period of time, the sensor adapted for measuring movement of at least one of the subject'"'"'s extremities and to be in wired or wireless communication with a processor, the sensor and processor being part of a movement disorder monitoring device further comprising a memory, the processor adapted to process and analyze data collected with the at least one sensor and further to quantify severity of the subject'"'"'s movement disorder symptoms; c) using the at least one sensor to collect movement data from the subject over a period of time; d) preprocessing measured movement data with the processor of the movement disorder monitoring device; e) quantifying severity of the subject'"'"'s movement disorder symptoms with the processor of the movement disorder monitoring device; f) recording, by the subject, a journal or diary entry through an input on the movement disorder monitoring device at the subject'"'"'s discretion; g) transmitting the preprocessed movement data, quantified symptom severity, and/or journal or diary entry to a remote database; h) analyzing the preprocessed movement data, quantified symptom severity, and/or journal or diary entry with a second processor to determine the efficacy of the drug or DBS therapy at alleviating the subject'"'"'s Parkinson'"'"'s disease symptoms and to determine whether the dose of drug or DBS therapy administered to the subject should be changed; and i) adjusting the subject'"'"'s dose of drug or DBS parameters according to the results of the analysis. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method of monitoring the efficacy of a drug or deep brain stimulation (DBS) therapy during treatment at alleviating a specific subject'"'"'s Parkinson'"'"'s disease symptoms, the method comprising the steps of:
-
a) administering at least one dose of a drug or DBS therapy treatment to the specific subject; b) applying at least one sensor to the specific subject, the at least one sensor adapted for measuring movement of at least one of the specific subject'"'"'s extremities and to be in wired or wireless communication with a processor, the sensor and processor being part of a movement disorder monitoring device, the processor adapted to store data and to correlate data between the movement disorder monitoring device and external devices; c) using the at least one sensor to collect movement data from the specific subject over a period of time; d) preprocessing measured movement data with the processor of the movement disorder monitoring device; e) quantifying severity of the subject'"'"'s movement disorder symptoms with the processor of the movement disorder monitoring device; f) recording, by the subject, a journal or diary entry through an input on the movement disorder monitoring device at the subject'"'"'s discretion; g) analyzing the collected data to determine the efficacy of the drug or DBS therapy at alleviating the specific subject'"'"'s Parkinson'"'"'s disease symptoms and to determine whether the dose of drug or DBS therapy administered to the specific subject should be changed; and h) adjusting the specific subject'"'"'s dose of drug or DBS parameters according to the results of the analysis, wherein the movement disorder monitoring device is adapted to transmit measured data to a remote database in near real-time as data is collected from the subject and the preprocessed movement data, quantified symptom severity, and/or journal or diary entry are consolidated into a report via software on the second processor and indexed and displayed relative to time for viewing and/or analysis by a clinician, physician, and/or the subject to provide an ordered measure of how the data or a subject'"'"'s symptoms change over time. - View Dependent Claims (9, 10, 11, 12, 13)
-
-
14. A method of monitoring the efficacy of either a drug or deep brain stimulation (DBS) therapy during treatment at alleviating a specific subject'"'"'s Parkinson'"'"'s disease symptoms, the method comprising the steps of:
-
a) administering at least one dose of a drug or DBS therapy treatment to the specific subject; b) applying at least one sensor to the specific subject, the sensor adapted for measuring movement of at least one of the subject'"'"'s extremities and to be in wired or wireless communication with a processor, the sensor and processor being part of a movement disorder monitoring device further comprising a memory, the processor adapted to process and analyze data collected with the at least one sensor and further to quantify severity of the subject'"'"'s movement disorder symptoms; c) using the at least one sensor to collect movement data from the specific subject over a period of time; d) preprocessing measured movement data with the processor of the movement disorder monitoring device; e) quantifying severity of the subject'"'"'s movement disorder symptoms with the processor of the movement disorder monitoring device; f) transmitting the preprocessed movement data and/or quantified symptom severity to a remote database; g) analyzing the collected preprocessed movement data and/or the quantified symptom severity with a second processor to determine the efficacy of the drug or DBS therapy at alleviating the subject'"'"'s Parkinson'"'"'s disease symptoms and to determine whether the dose of drug or DBS therapy administered to the specific subject should be changed; and h) adjusting the specific subject'"'"'s dose of drug or DBS parameters, if necessary, according to the results of the analysis, wherein the movement disorder monitoring device is adapted to transmit preprocessed movement data and/or quantified symptom severity to the remote data base in near real-time as data is collected from the subject. - View Dependent Claims (15, 16, 17, 18, 19)
-
Specification